219 related articles for article (PubMed ID: 30905014)
1. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.
Minlikeeva AN; Cannioto R; Jensen A; Kjaer SK; Jordan SJ; Diergaarde B; Szender JB; Odunsi K; Almohanna H; Mayor P; Starbuck K; Zsiros E; Bandera EV; Cramer DW; Doherty JA; DeFazio A; ; Edwards R; Goode EL; Goodman MT; Høgdall E; Matsuo K; Mizuno M; Nagle CM; Ness RB; Paddock LE; Pearce CL; Risch HA; Rossing MA; Terry KL; Wu AH; Modugno F; Webb PM; Moysich KB;
Cancer Causes Control; 2019 May; 30(5):537-547. PubMed ID: 30905014
[TBL] [Abstract][Full Text] [Related]
2. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer.
Kjaerbye-Thygesen A; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):798-803. PubMed ID: 16614126
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
Praestegaard C; Jensen A; Jensen SM; Nielsen TS; Webb PM; Nagle CM; DeFazio A; ; Høgdall E; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Moysich K; Ness RB; Edwards R; Matsuo K; Hosono S; Goode EL; Winham SJ; Fridley BL; Cramer DW; Terry KL; Schildkraut JM; Berchuck A; Bandera EV; Paddock LE; Massuger LF; Wentzensen N; Pharoah P; Song H; Whittemore A; McGuire V; Sieh W; Rothstein J; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike M; Lee AW; Sutphen R; Chang-Claude J; Risch HA; Kjaer SK;
Int J Cancer; 2017 Jun; 140(11):2422-2435. PubMed ID: 28063166
[TBL] [Abstract][Full Text] [Related]
4. Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative.
Zhou Y; Chlebowski R; LaMonte MJ; Bea JW; Qi L; Wallace R; Lavasani S; Walsh BW; Anderson G; Vitolins M; Sarto G; Irwin ML
Gynecol Oncol; 2014 Apr; 133(1):4-10. PubMed ID: 24680584
[TBL] [Abstract][Full Text] [Related]
5. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer.
Kelemen LE; Warren GW; Koziak JM; Köbel M; Steed H
Gynecol Oncol; 2016 Jan; 140(1):124-30. PubMed ID: 26549109
[TBL] [Abstract][Full Text] [Related]
6. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
Cannioto RA; LaMonte MJ; Kelemen LE; Risch HA; Eng KH; Minlikeeva AN; Hong CC; Szender JB; Sucheston-Campbell L; Joseph JM; Berchuck A; Chang-Claude J; Cramer DW; DeFazio A; Diergaarde B; Dörk T; Doherty JA; Edwards RP; Fridley BL; Friel G; Goode EL; Goodman MT; Hillemanns P; Hogdall E; Hosono S; Kelley JL; Kjaer SK; Klapdor R; Matsuo K; Odunsi K; Nagle CM; Olsen CM; Paddock LE; Pearce CL; Pike MC; Rossing MA; Schmalfeldt B; Segal BH; Szamreta EA; Thompson PJ; Tseng CC; Vierkant R; Schildkraut JM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Ness RB; Jensen A; Webb PM; Terry K; Bandera EV; Moysich KB
Br J Cancer; 2016 Jun; 115(1):95-101. PubMed ID: 27299959
[TBL] [Abstract][Full Text] [Related]
7. Prediagnosis and postdiagnosis smoking and survival following diagnosis with ovarian cancer.
Wang T; Townsend MK; Simmons V; Terry KL; Matulonis UA; Tworoger SS
Int J Cancer; 2020 Aug; 147(3):736-746. PubMed ID: 31693173
[TBL] [Abstract][Full Text] [Related]
8. Germline BRCA variants, lifestyle and ovarian cancer survival.
Gersekowski K; Delahunty R; Alsop K; Goode EL; Cunningham JM; Winham SJ; Pharoah P; Song H; Jordan S; Fereday S; DeFazio A; Friedlander M; Obermair A; ; ; Webb PM
Gynecol Oncol; 2022 Jun; 165(3):437-445. PubMed ID: 35400525
[TBL] [Abstract][Full Text] [Related]
9. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
Cannioto R; LaMonte MJ; Risch HA; Hong CC; Sucheston-Campbell LE; Eng KH; Brian Szender J; Chang-Claude J; Schmalfeldt B; Klapdor R; Gower E; Minlikeeva AN; Zirpoli GR; Bandera EV; Berchuck A; Cramer D; Doherty JA; Edwards RP; Fridley BL; Goode EL; Goodman MT; Hogdall E; Hosono S; Jensen A; Jordan S; ; Kjaer SK; Matsuo K; Ness RB; Olsen CM; Olson SH; Leigh Pearce C; Pike MC; Anne Rossing M; Szamreta EA; Thompson PJ; Tseng CC; Vierkant RA; Webb PM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Schildkraut JM; Terry KL; Kelemen LE; Moysich KB
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1114-24. PubMed ID: 27197285
[TBL] [Abstract][Full Text] [Related]
10. Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women.
Urbute A; Frederiksen K; Kjaer SK
Ann Epidemiol; 2022 Jun; 70():61-67. PubMed ID: 35405346
[TBL] [Abstract][Full Text] [Related]
11. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
[TBL] [Abstract][Full Text] [Related]
13. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.
Brieger KK; Phung MT; Mukherjee B; Bakulski KM; Anton-Culver H; Bandera EV; Bowtell DDL; Cramer DW; DeFazio A; Doherty JA; Fereday S; Fortner RT; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Matsuo K; Menon U; Modugno F; Moysich KB; Qin B; Ramus SJ; Risch HA; Rossing MA; Schildkraut JM; Trabert B; Vierkant RA; Winham SJ; Wentzensen N; Wu AH; Ziogas A; Khoja L; Cho KR; McLean K; Richardson J; Grout B; Chase A; Deurloo CM; Odunsi K; Nelson BH; Brenton JD; Terry KL; Pharoah PDP; Berchuck A; Hanley GE; Webb PM; Pike MC; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):443-452. PubMed ID: 34789471
[TBL] [Abstract][Full Text] [Related]
14. A healthy lifestyle and survival among women with ovarian cancer.
Hansen JM; Nagle CM; Ibiebele TI; Grant PT; Obermair A; Friedlander ML; DeFazio A; Webb PM;
Int J Cancer; 2020 Dec; 147(12):3361-3369. PubMed ID: 32542708
[TBL] [Abstract][Full Text] [Related]
15. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
Minlikeeva AN; Freudenheim JL; Cannioto RA; Szender JB; Eng KH; Modugno F; Ness RB; LaMonte MJ; Friel G; Segal BH; Odunsi K; Mayor P; Zsiros E; Schmalfeldt B; Klapdor R; Dӧrk T; Hillemanns P; Kelemen LE; Kӧbel M; Steed H; de Fazio A; ; Jordan SJ; Nagle CM; Risch HA; Rossing MA; Doherty JA; Goodman MT; Edwards R; Matsuo K; Mizuno M; Karlan BY; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Terry KL; Cramer DW; Bandera EV; Paddock LE; Kiemeney LA; Massuger LF; Kupryjanczyk J; Berchuck A; Chang-Claude J; Diergaarde B; Webb PM; Moysich KB;
Cancer Causes Control; 2017 May; 28(5):469-486. PubMed ID: 28293802
[TBL] [Abstract][Full Text] [Related]
16. Height, weight, BMI and ovarian cancer survival.
Kotsopoulos J; Moody JR; Fan I; Rosen B; Risch HA; McLaughlin JR; Sun P; Narod SA
Gynecol Oncol; 2012 Oct; 127(1):83-7. PubMed ID: 22713293
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.
Fortner RT; Poole EM; Wentzensen NA; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Clendenen TV; Fournier A; Fraser G; Gapstur SM; Gaudet MM; Giles GG; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Kaaks R; Kirsh VA; Knutsen S; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Milne RL; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sánchez MJ; Schairer C; Schouten LJ; Tjonneland A; Townsend MK; Travis RC; Trichopoulou A; van den Brandt PA; Vineis P; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
Int J Cancer; 2019 Jul; 145(1):58-69. PubMed ID: 30561796
[TBL] [Abstract][Full Text] [Related]
18. Weight Gain and the Risk of Ovarian Cancer in
Kim SJ; Lubinski J; Huzarski T; Møller P; Armel S; Karlan BY; Senter L; Eisen A; Foulkes WD; Singer CF; Tung N; Bordeleau L; Neuhausen SL; Olopade OI; Eng C; Weitzel JN; Fruscio R; Narod SA; Kotsopoulos J;
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2038-2043. PubMed ID: 34426412
[TBL] [Abstract][Full Text] [Related]
19. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
20. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
Nagle CM; Dixon SC; Jensen A; Kjaer SK; Modugno F; deFazio A; Fereday S; Hung J; Johnatty SE; ; Fasching PA; Beckmann MW; Lambrechts D; Vergote I; Van Nieuwenhuysen E; Lambrechts S; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Chang-Claude J; Goodman MT; Ness RB; Moysich K; Heitz F; du Bois A; Harter P; Schwaab I; Matsuo K; Hosono S; Goode EL; Vierkant RA; Larson MC; Fridley BL; Høgdall C; Schildkraut JM; Weber RP; Cramer DW; Terry KL; Bandera EV; Paddock L; Rodriguez-Rodriguez L; Wentzensen N; Yang HP; Brinton LA; Lissowska J; Høgdall E; Lundvall L; Whittemore A; McGuire V; Sieh W; Rothstein J; Sutphen R; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Webb PM;
Br J Cancer; 2015 Sep; 113(5):817-26. PubMed ID: 26151456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
